Cite
HARVARD Citation
Guo, N. et al. (2022). Inhibiting nonhomologous end-joining repair would promote the antitumor activity of gemcitabine in nonsmall cell lung cancer cell lines. Anti-cancer drugs. 33 (5), pp. 502-508. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Guo, N. et al. (2022). Inhibiting nonhomologous end-joining repair would promote the antitumor activity of gemcitabine in nonsmall cell lung cancer cell lines. Anti-cancer drugs. 33 (5), pp. 502-508. [Online].